Table 3 The gene complexes which are potentially associated to cancer processes
Complex name | p value | Number of genes associated | Number of variances found | Tumour tissue | Control tissue |
|---|---|---|---|---|---|
Mucin | 9.54E-05 | 3: MUC2, MUC4, MUC6 | 27 | 1 | 0 |
Bcl9-Cbp/p300-Ctnnb1-Lef/Tcf | 2.46E-03 | 2: CREBBP, TCF3 | 2 | 1 | 0 |
Sox | 4.55E-03 | 2: SOX7, SOX10 | 2 | 1 | 0 |
Cholesterol monooxygenase (side-chain-cleaving) | 1.06E-02 | 1 | 1 | 1 | 0 |
CYP11A | 1.06E-02 | 1 | 1 | 1 | 0 |
Sarcosine dehydrogenase | 1.06E-02 | 1 | 1 | 1 | 0 |
Ctbp | 1.59E-02 | 1 | 7 | 1 | 0 |
Cbp/p300 | 1.59E-02 | 1 | 1 | 1 | 0 |
Dimethylglycine dehydrogenase | 1.59E-02 | 1 | 1 | 1 | 0 |
DRD1/5 | 1.59E-02 | 1 | 1 | 1 | 0 |
MAGI | 2.64E-02 | 1 | 2 | 1 | 1 |
Magi-Pten | 3.68E-02 | 1 | 2 | 1 | 1 |
Fumarylacetoacetase | 1.06E-02 | 1 | 1 | 1 | 1 |